Avelumab With Decitabine as First Line for AML Treatment of Patients With AML, Who Are Unfit for Intensive Chemotherapy
Status:
Terminated
Trial end date:
2019-05-15
Target enrollment:
Participant gender:
Summary
The goal of this study is to test the safety of combination treatment with Avelumab and
Decitabine in newly diagnosed AML patients who are unfit for intensive induction
chemotherapy.